These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10755532)

  • 1. Detection of anti-HLA antibody by flow cytometry in patients with a left ventricular assist device is associated with early rejection following heart transplantation.
    DeNofrio D; Rho R; Morales FJ; Kamoun M; Kearns J; Dorozinsky C; Rosengard BR; Acker MA; Loh E
    Transplantation; 2000 Mar; 69(5):814-8. PubMed ID: 10755532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
    Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
    Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival.
    Pagani FD; Dyke DB; Wright S; Cody R; Aaronson KD
    J Heart Lung Transplant; 2001 Jun; 20(6):646-53. PubMed ID: 11404170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices.
    Gonzalez-Stawinski GV; Atik FA; McCarthy PM; Roselli EE; Hoercher K; Navia JL; Smedira NG; Starling RC; Young JB; Cook DJ
    Transplant Proc; 2005 Mar; 37(2):1349-51. PubMed ID: 15848717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA and MICA allosensitization patterns among patients supported by ventricular assist devices.
    Askar M; Hsich E; Reville P; Nowacki AS; Baldwin W; Bakdash S; Daghstani J; Zhang A; Klingman L; Smedira N; Moazami N; Taylor DO; Starling RC; Gonzalez-Stawinski G
    J Heart Lung Transplant; 2013 Dec; 32(12):1241-8. PubMed ID: 24075503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
    Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
    Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with anti-human leukocyte antigen antibodies in patients supported with continuous-flow devices and effect on probability of transplant and post-transplant outcomes.
    Alba AC; Tinckam K; Foroutan F; Nelson LM; Gustafsson F; Sander K; Bruunsgaard H; Chih S; Hayes H; Rao V; Delgado D; Ross HJ
    J Heart Lung Transplant; 2015 May; 34(5):685-92. PubMed ID: 25638296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of anti-HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantation.
    Müller-Steinhardt M; Fricke L; Kirchner H; Hoyer J; Klüter H
    Clin Transplant; 2000 Feb; 14(1):85-9. PubMed ID: 10693642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preformed anti-human leukocyte antigen antibodies jeopardize cardiac transplantation in patients with a left ventricular assist device.
    Goffinet J; St Pierre Schneider B
    Heart Lung; 2002; 31(2):122-30; quiz, 131-2. PubMed ID: 11910387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing HLA sensitization in implantable LVAD recipients.
    Massad MG; Cook DJ; Schmitt SK; Smedira NG; McCarthy JF; Vargo RL; McCarthy PM
    Ann Thorac Surg; 1997 Oct; 64(4):1120-5. PubMed ID: 9354538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
    Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
    Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LVAD implant as a bridge to heart transplantation is associated with allosensitization as measured by single antigen bead assay.
    Shankar N; Daly R; Geske J; Kushwaha SK; Timmons M; Joyce L; Stulak J; Gandhi M; Kremers W; Park S; Pereira NL
    Transplantation; 2013 Aug; 96(3):324-30. PubMed ID: 23743727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of anti-HLA antibodies associated with ventricular assist device use in pediatric patients: A United Network for Organ Sharing database analysis.
    Magdo HS; Schumacher KR; Yu S; Gajarski RJ; Friedland-Little JM
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28568969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigen sensitization in ventricular assist device recipients: a lesser risk with the DeBakey axial pump.
    Grinda JM; Bricourt MO; Amrein C; Salvi S; Guillemain R; Francois A; Guibourt P; Deloche A; Fabiani JN
    Ann Thorac Surg; 2005 Sep; 80(3):945-8. PubMed ID: 16122460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic sensitization in recipients of left ventricular assist devices.
    John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
    Kirsch L; Timmermans T; Van Caenegem O; Gurne O; Noirhomme P; Jacquet LM; Latinne D; Poncelet AJ
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
    Drakos SG; Kfoury AG; Long JW; Stringham JC; Fuller TC; Nelson KE; Campbell BK; Gilbert EM; Renlund DG
    Ann Thorac Surg; 2006 Sep; 82(3):889-93. PubMed ID: 16928502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular rejection post heart transplantation is associated with positive flow cytometric cross-matching.
    McCarthy JF; Cook DJ; Massad MG; Sano Y; O'Malley KJ; Ratliff NR; Stewart RW; Smedira NG; Starling RC; Young JB; McCarthy PM
    Eur J Cardiothorac Surg; 1998 Aug; 14(2):197-200. PubMed ID: 9755007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.